HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lipids

A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed)
Also Known As:
Lipid
Networked: 114793 relevant articles (5634 outcomes, 16689 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Azizi, Fereidoun: 271 articles (10/2022 - 02/2002)
2. Mirmiran, Parvin: 124 articles (09/2022 - 01/2005)
3. Ballantyne, Christie M: 115 articles (01/2022 - 03/2002)
4. Serhan, Charles N: 114 articles (01/2022 - 01/2002)
5. Wang, Wei: 107 articles (12/2022 - 01/2004)
6. Zhang, Li: 102 articles (09/2022 - 08/2004)
7. Li, Yan: 100 articles (07/2022 - 03/2005)
8. Shulman, Gerald I: 100 articles (01/2022 - 03/2002)
9. Kastelein, John J P: 91 articles (04/2022 - 10/2002)
10. Banach, Maciej: 90 articles (04/2022 - 12/2005)

Related Diseases

1. Insulin Resistance
2. Body Weight (Weight, Body)
04/12/2023 - "According to the experimental results, PPPs were most effective in reducing the body weight and serum and liver lipid levels. "
04/21/2005 - "Compared with the NASH group, there were no significant changes in body weight, liver weight, blood biochemical index, the degree of hepatic steatosis, and histological activity index (HAI) score in the UDCA group; however, body and liver weights were significantly decreased, and the degree of steatosis was markedly improved in rats of both the LCD group and the UDCA+LCD group, but significant improvement with regard to serum lipid variables and hepatic inflammatory changes were seen only in rats of the UDCA+LCD group, and not in the LCD group. "
09/01/2021 - "In in vivo studies, LBPs significantly inhibited body weight gain, reduced lipid levels in serum and liver, and improved oxidative damage in a dose-dependent manner in mice fed a high-fat diet. "
01/25/2014 - "CNX-012-570, a direct AMPK activator provides strong glycemic and lipid control along with significant reduction in body weight; studies from both diet-induced obese mice and db/db mice models."
12/01/2012 - "After the 12-week study, the Doenjang supplementation group had significant reductions in body weight (kg), body fat mass (kg) and body fat (%) compared to the placebo group, the supplementation of Doenjang resulted in a significant reduction in visceral fat (cm(2)), although no changes were observed in total and subcutaneous fat are as (cm(2)), serum lipid profiles and dietary intakes. "
3. Inflammation (Inflammations)
4. Obesity
5. Weight Loss (Weight Reduction)

Related Drugs and Biologics

1. Glucose (Dextrose)
2. Insulin (Novolin)
3. Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
4. Blood Glucose (Blood Sugar)
5. Cholesterol
6. Triglycerides (Triacylglycerol)
7. Antioxidants
8. oxidized low density lipoprotein
9. Proteins (Proteins, Gene)
10. Lipids

Related Therapies and Procedures

1. Therapeutics
2. Glycemic Control
3. Secondary Prevention
4. Oral Administration
5. Drug Therapy (Chemotherapy)